- Reaction score
- 217
JW Pharmaceutical said Monday that it would begin pre-clinical trial for CWL08006, a new concept of hair loss treatment using Wnt signaling pathway, jointly with the School of Medicine at the University of Pennsylvania.
http://m.koreabiomed.com/news/articleView.html?idxno=1738
http://m.koreabiomed.com/news/articleView.html?idxno=1738